JORGE E CORTES to Immunocompromised Host
This is a "connection" page, showing publications JORGE E CORTES has written about Immunocompromised Host.
Connection Strength
0.010
-
Phase II study of alemtuzumab in chronic lymphoproliferative disorders. Cancer. 2003 Aug 15; 98(4):773-8.
Score: 0.010
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.